Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between the two are due to...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same author

ABO-Incompatible Platelet Transfusions and Mortality Risk in Patients With Intracranial Hemorrhage.

Neurosurgery·2026
Same author

Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1/CTLA-4 bispecific antibody.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Elevated glioma-related cortical glutamate <i>in vivo</i> is associated with <i>ex vivo</i> interictal discharges in human brain slices.

Brain communications·2025
Same author

Rheumatoid arthritis-associated interstitial lung disease: an overview.

QJM : monthly journal of the Association of Physicians·2025
Same author

Diffuse Alveolar Hemorrhage.

Seminars in respiratory and critical care medicine·2025
Same journal

Gamma Knife, its optimal use - a Letter.

British journal of neurosurgery·2026
Same journal

Preoperative visualization and intraoperative functional assessment of a long medullary artery in glioblastoma surgery using ultra-high-resolution intra-arterial Computed tomography angiography: an illustrative case.

British journal of neurosurgery·2026
Same journal

Robotic platforms in neurosurgery: the great disappearing act.

British journal of neurosurgery·2026
Same journal

Morphological parameters contributing to aneurysm rupture: Identifying the rogue from the mugshot using different statistical methods.

British journal of neurosurgery·2026
Same journal

Does early surgical intervention for type II dens fractures improve survival in octogenarians? A propensity-matched analysis.

British journal of neurosurgery·2026
Same journal

A single-centre experience of fluoroscopic-guided erector spinae plane blocks in degenerative lumbar spine surgery.

British journal of neurosurgery·2026
See all related articles

Related Experiment Videos

Equipoise and randomisation in surgery.

Patrick Mitchell

    British Journal of Neurosurgery
    |February 18, 2010
    PubMed
    Summary
    This summary is machine-generated.

    The randomized controlled trial model, effective for drugs, poorly fits surgical procedures due to issues like equipoise. Reality should adapt to the model, not vice-versa, in surgical research.

    Related Experiment Videos

    Area of Science:

    • Medical research methodology
    • Surgical innovation
    • Clinical trial design

    Background:

    • The established randomized controlled trial (RCT) model, widely adopted from pharmaceutical research, faces significant challenges when applied to surgical interventions.
    • Key reasons for this poor fit include inherent differences in surgical procedures compared to drug administration, particularly concerning patient blinding and the concept of equipoise.

    Discussion:

    • The letter by Helmy et al. exemplifies attempts to force surgical reality to conform to the drug-trial-based RCT model.
    • This approach overlooks the fundamental principle of scientific progress: adapting models to better fit observed reality.
    • The ethical and practical complexities of surgical equipoise are a major point of contention in applying standard RCTs.

    Key Insights:

    • Randomized trials in surgery are not a perfect fit due to fundamental differences from drug trials.
    • The principle of equipoise, crucial for ethical trials, is particularly problematic in surgical contexts.
    • Scientific models should evolve to fit reality, rather than attempting to reshape reality to fit a flawed model.

    Outlook:

    • Future surgical research requires adaptive trial designs that acknowledge the unique nature of surgical procedures.
    • Revisiting and refining the concept of equipoise in surgery is essential for ethical and effective clinical trials.
    • A paradigm shift may be needed, moving beyond rigid adherence to drug trial models for surgical innovation.